Full Text View
Tabular View
No Study Results Posted
Related Studies
Impact of Diabetes and Glucose Control During Rehabilitation After Stroke
This study has been suspended.
First Received: October 18, 2005   Last Updated: February 3, 2009   History of Changes
Sponsors and Collaborators: Melbourne Health
National Health and Medical Research Council, Australia
Information provided by: Melbourne Health
ClinicalTrials.gov Identifier: NCT00241956
  Purpose

To assess whether patients with diabetes have less clinical improvement during inpatient rehabilitation than those without diabetes and whether hyperglycaemia during rehabilitation is an adverse prognostic indicator.


Condition
Cerebrovascular Accident
Diabetes
Hyperglycemia

MedlinePlus related topics: Diabetes Rehabilitation
U.S. FDA Resources
Study Type: Observational
Study Design: Retrospective
Official Title: Impact of Diabetes and Glucose Control During Rehabilitation After Stroke

Further study details as provided by Melbourne Health:

Estimated Enrollment: 120
Study Start Date: October 2005
Detailed Description:

Patients with diabetes have a higher mortality rate and more severe disability from stroke compared to those without diabetes. Those with hyperglycaemia tend to progress to a larger final stroke size. Diabetes and hyperglycaemia may affect the ability of the patient to clinically improve, independent of the degree of initial impairment. We will perform a retrospective review of medical records of stroke patients admitted to an inpatient rehabilitation unit. We will compare outcomes of changes in disability scales (FIM and Barthel) from admission to discharge, length of stay and hospital events between those with and without diabetes. Amongst those with diabetes, we will also assess whether those with higher mean blood glucose levels during their inpatient rehabilitation stay have worse outcomes.

  Eligibility

Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Inpatient rehabilitation for acute stroke

Exclusion Criteria:

  • Medical records unavailable
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00241956

Locations
Australia, Victoria
The Royal Melbourne Hospital
Melbourne, Victoria, Australia, 3050
Sponsors and Collaborators
Melbourne Health
National Health and Medical Research Council, Australia
Investigators
Principal Investigator: Leo Rando, MBBS FRACP Melbourne Health
  More Information

No publications provided

Study ID Numbers: 2004.246
Study First Received: October 18, 2005
Last Updated: February 3, 2009
ClinicalTrials.gov Identifier: NCT00241956     History of Changes
Health Authority: Australia: Department of Health and Ageing Therapeutic Goods Administration

Study placed in the following topic categories:
Metabolic Diseases
Cerebral Infarction
Stroke
Vascular Diseases
Diabetes Mellitus
Central Nervous System Diseases
Endocrine System Diseases
Ischemia
Brain Diseases
Cerebrovascular Disorders
Hyperglycemia
Brain Ischemia
Endocrinopathy
Brain Infarction
Infarction
Glucose Metabolism Disorders
Metabolic Disorder

Additional relevant MeSH terms:
Metabolic Diseases
Cerebral Infarction
Stroke
Nervous System Diseases
Vascular Diseases
Diabetes Mellitus
Endocrine System Diseases
Central Nervous System Diseases
Brain Diseases
Cerebrovascular Disorders
Hyperglycemia
Brain Ischemia
Cardiovascular Diseases
Brain Infarction
Glucose Metabolism Disorders

ClinicalTrials.gov processed this record on May 07, 2009